Innospec (IOSP) investor relations material

Executive summary

• Revenues rose 12% year-over-year to $491.4 million, with double-digit operating income growth across all business segments, notably in Performance Chemicals and Oilfield Services.

• Net income attributable to shareholders was $30.8 million ($1.25 per diluted share), up from $23.5 million ($0.94 per share) last year.

• Adjusted non-GAAP EPS was $1.27, nearly flat compared to $1.26 a year ago; GAAP EPS included a $0.02 per share negative impact from special items.

• All segments—Performance Chemicals, Fuel Specialties, and Oilfield Services—reported sales and operating income growth, with Fuel Specialties maintaining margins despite some compression.

• DRA plant expansion and North Carolina plant upgrades supported segment growth and are expected to further boost capacity and efficiency.

Financial highlights

• Net sales increased 12% to $491.4 million; gross profit was $138.3 million, with gross margin at 28.1%.

• Adjusted EBITDA was $50.1 million, up from $49.1 million year-over-year.

• Net income attributable to the company was $30.8 million, up from $23.5 million a year ago.

• Cash and cash equivalents at quarter-end were $250.2 million, with no debt.

• Semi-annual dividend of $0.92 per share paid; $6.4 million in share repurchases completed.

Outlook and guidance

• Management expects further operating income growth in Performance Chemicals and Oilfield Services in the second half of 2026, with steady performance in Fuel Specialties.

• Anticipate margin headwinds in Fuel Specialties in Q3 due to pricing lag, but expect stabilization if raw material prices stabilize.

• Additional capacity and volume improvements in Performance Chemicals expected in late Q4 and into Q1 2027.

• Increased operating cash flow anticipated as working capital efficiency improves.